Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers.

Berg, Janna; Ramberg, Christina; Haugstvedt, Jon Olav Sulheim; Bengtson, May-Bente; Gabrielsen, Anne-Marie; Brustugun, Odd Terje; Halvorsen, Ann Rita; Helland, Åslaug

Berg, Janna; Ramberg, Christina; Haugstvedt, Jon Olav Sulheim; Bengtson, May-Bente; Gabrielsen, Anne-Marie; Brustugun, Odd Terje; Halvorsen, Ann Rita; Helland, Åslaug.

Afiliação

Berg J; Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway.
Ramberg C; Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Haugstvedt JOS; Department of Medical Physics, Oslo University Hospital, Oslo, Norway.
Bengtson MB; Department of Radiology and Nuclear Medicine, Vestfold Hospital Trust, Tønsberg, Norway.
Gabrielsen AM; Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway.
Brustugun OT; Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway.
Halvorsen AR; Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Helland Å; Section of Oncology, Vestre Viken Hospital Trust, Drammen, Norway.

Front Oncol ; 11: 674731, 2021.

Article em En | MEDLINE | ID: mdl-34109123

Palavras-chave

non-small cell lung cancer (NSCLC); pulmonary function test; radiation pneumonitis; radiotherapy dose-volume; stereotactic body radiation therapy (SBRT); toxicity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google